Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3

2(50.0%)

N/A

1(25.0%)

Phase 2

1(25.0%)

4Total

Phase 3(2)

N/A(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT00980486Completed

Obesity and Antibiotic Tissue Concentration

Role: lead

NCT00837278Unknown

Maternal Serum Cytokine Levels and Angiogenic Factor Levels in IVF vs Spontaneously Conceived Pregnancies

Role: lead

NCT00811603Phase 3Completed

Trial Comparing the Optimal Timing of Antibiotic Prophylaxis at the Time of Cesarean Delivery

Role: lead

NCT00810914Not ApplicableUnknown

Patient Controlled Epidural Analgesia Versus Continuous Epidural Infusion: Obstetrical and Neonatal Outcomes

Role: lead

NCT00641784Phase 3Terminated

Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population

Role: lead

NCT00870428Unknown

Predicitve Use of Spot Urine Protein/Creatinine Ratios in Preeclampsia

Role: lead

NCT00326521Unknown

Evaluation of Fever Occurring in Labor in Patients Receiving Epidural Anesthesia

Role: lead

NCT00569439Phase 2Completed

A Study on the Effects of Dextrose Solutions on the Course of Labor

Role: lead

All 8 trials loaded